Rosys-FT 145mg/10mg Tablet is a combination of two lipid-lowering medicines: Fenofibrate and rosuvastatin. Fenofibrate works by lowering the levels of triglycerides in your blood, while atorvastatin prevents your body from making "bad" cholesterol (LDL). Both raise the levels of “good” cholesterol (HDL).
Taking alcohol with Rosuvastatin increases the chances of liver dysfunction.
Rosys-FT 145mg/10mg Tablet is highly unsafe to use during pregnancy. Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
Rosys-FT 145mg/10mg Tablet is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
Rosys-FT 145mg/10mg Tablet does not usually affect your ability to drive.
Rosys-FT 145mg/10mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Rosys-FT 145mg/10mg Tablet may be needed. Please consult your doctor. Use of Rosys-FT 145mg/10mg Tablet is not recommended in patients with severe kidney disease.
Rosys-FT 145mg/10mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Rosys-FT 145mg/10mg Tablet may be needed. Please consult your doctor. Use of Rosys-FT 145mg/10mg Tablet is not recommended in patients with severe liver disease and active liver disease.
“The following are the results of on-going survey on 1mg.com for Rosys-FT 145mg/10mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 3rd Jul 2017.